## QRVO: Qorvo, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.19 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-2.0% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($81.79)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.07M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.2% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Blackrock Inc.: 12.1% (-17.1%)
- Vanguard Group Inc: 12.0% (+0.9%)
- Starboard Value LP: 8.1% (-4.6%)
- State Street Corpora: 3.8% (-5.4%)
- FIL LTD: 3.5% (-9.2%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.0% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.19 indicates undervaluation relative to growth. Balance sheet: strong liquidity (3.0x). Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $8.0B |
| Beta | 1.37 |
| 52W Range | $49.46 - $106.30 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.19 |
| Forward P/E | 12.3 |
| Current P/E | 13.6 |
| YoY Growth | 10.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.5% to -1.4% (-2.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.4pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.05x) but short-term weakness (below SMA20). RSI neutral at 47. OFD pattern: -DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.44% (CS: 30) | Neutral |
| RSI_14 | 47.3 | Neutral |
| MACD Histogram | -0.17 | Bearish |
| vs SMA20 | 0.991x | Below |
| vs SMA50 | 0.980x | Below |
| vs SMA200 | 1.050x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $86.45
- **Stop Loss:** $81.79 (5.4% risk)
- **Target:** $95.77 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 257
- **Position Value:** $22,217.65
- **Portfolio %:** 22.22%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-27 (Est: $1.86)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.11 | $2.22 | +5.1% |
| 2025Q2 | $0.63 | $0.92 | +46.2% |
| 2025Q1 | $1.00 | $1.42 | +41.6% |
| 2024Q4 | $1.21 | $1.61 | +33.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*